Nick DeSanctis is a pharmaceutical executive with over 25 years of leadership experience in the industry and is an expert in New Product Planning and driving portfolio value through areas such as Portfolio Management, Life Cycle Management, Target Value Profile Development, and Therapeutic Area Strategy. Nick also has extensive global experience developing strong business – R&D cross-functional planning and integrated decision-making.  His background includes building and leading the New Product Planning function, strategic pipeline development, global and US-based marketing, and field operations experience. 

Prior to RxC International, Nick served as Vice President of New Product Planning for Daiichi Sankyo, where he led the formation of the New Product Planning function. He worked closely with R&D on early to late-stage go/no-go development decisions, product prioritization, and therapeutic area strategy.  He was also responsible for the identification and business analysis of in-licensing opportunities necessary to build strategic alliances.  Nick played a key role in both early business planning and pipeline decision-making as a core member of several executive management committees at Daiichi Sankyo Inc. Earlier in his career, Nick worked at Bristol-Myers Squibb, where he held leadership positions in the Worldwide Franchise Management Group, US Marketing and Field Management. During his tenure at BMS, he received multiple management performance awards.  

Nick has a B.S. in Pharmacy and an M.B.A. in Marketing from Rutgers University.

Recent Publications

Uncover Potential Life Cycle Opportunities in Oncology Using Patient-Centric Outcomes

Pharmaceutical Executive · Mar 19, 2021

Maximize New Product Potential Through Early Commercial Planning

Pharmaceutical Executive · Nov 15, 2019